[{"address1": "Dr. Neergaards Vej", "address2": "5th Floor", "city": "Horsholm", "zip": "2970", "country": "Denmark", "phone": "45 31 31 97 53", "website": "https://evaxion.ai", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Evaxion A/S, a clinical-stage biotech company, develops artificial intelligence-powered immunology vaccines. The company develops EVX-01, which is in phase 2 global multi-center clinical trial for the treatment of metastatic melanoma; EVX-02, a DNA-based cancer vaccine that has completed Phase 1/2a trial to induce a therapeutic immune response in the adjuvant setting in patients with resected melanoma; and EVX-03, DNA-based cancer vaccine for the treatment of various cancers, including non-small cell lung cancer. Its programs also include vaccines that are in pre-clinical stage, which includes EVX-B1 for the prevention of S. aureus-induced skin and soft tissue infections in patients undergoing elective abdominal hernia surgery; EVX-B2 to target diseases caused by N. gonorrhoeae; EVX-B3 for eliciting strong humoral antibody and cellular immune response to the bacterial pathogen; and EVX-V1, a viral vaccine product candidate for targeting Cytomegalovirus. The company was formerly known as Evaxion Biotech A/S and changed its name to Evaxion A/S in May 2025. Evaxion A/S was incorporated in 2008 and is based in Horsholm, Denmark.", "fullTimeEmployees": 46, "companyOfficers": [{"maxAge": 1, "name": "Dr. Birgitte  Rono Ph.D.", "age": 47, "title": "Interim CEO & Chief Scientific Officer", "yearBorn": 1977, "fiscalYear": 2024, "totalPay": 343000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Andreas Holm Mattsson", "age": 48, "title": "Founder & Chief AI Officer", "yearBorn": 1976, "fiscalYear": 2024, "totalPay": 326000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Thomas Frederik Schmidt M.Sc.", "age": 53, "title": "Chief Financial Officer", "yearBorn": 1971, "fiscalYear": 2024, "totalPay": 77000, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 2.86, "open": 2.86, "dayLow": 2.811, "dayHigh": 2.94, "regularMarketPreviousClose": 2.86, "regularMarketOpen": 2.86, "regularMarketDayLow": 2.811, "regularMarketDayHigh": 2.94, "payoutRatio": 0.0, "beta": 0.137, "forwardPE": -2.2857144, "volume": 28284, "regularMarketVolume": 28284, "averageVolume": 115370, "averageVolume10days": 56930, "averageDailyVolume10Day": 56930, "bid": 2.11, "ask": 3.69, "bidSize": 2, "askSize": 2, "marketCap": 18191722, "fiftyTwoWeekLow": 1.2, "fiftyTwoWeekHigh": 17.75, "priceToSalesTrailing12Months": 5.5243616, "fiftyDayAverage": 2.6585, "twoHundredDayAverage": 3.719855, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 772409152, "profitMargins": 0.0, "floatShares": 155104950, "sharesOutstanding": 6316570, "sharesShort": 117813, "sharesShortPriorMonth": 42034, "sharesShortPreviousMonthDate": 1751241600, "dateShortInterest": 1753920000, "sharesPercentSharesOut": 0.0187, "heldPercentInsiders": 0.23066, "heldPercentInstitutions": 0.0682, "shortRatio": 1.03, "shortPercentOfFloat": 0.0247, "impliedSharesOutstanding": 6316570, "bookValue": -1.178, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1743379200, "netIncomeToCommon": -13341000, "trailingEps": -12.0, "forwardEps": -1.26, "lastSplitFactor": "1:5", "lastSplitDate": 1736812800, "enterpriseToRevenue": 234.561, "enterpriseToEbitda": -55.799, "52WeekChange": -0.8303387, "SandP52WeekChange": 0.15005577, "quoteType": "EQUITY", "currentPrice": 2.88, "targetHighPrice": 19.75, "targetLowPrice": 6.0, "targetMeanPrice": 13.25, "targetMedianPrice": 14.0, "recommendationMean": 1.5, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 3, "totalCash": 17843000, "totalCashPerShare": 0.065, "ebitda": -13842750, "totalDebt": 0, "totalRevenue": 3293000, "revenuePerShare": 1.482, "returnOnAssets": -0.37072, "returnOnEquity": -2.06437, "grossProfits": 3293000, "grossMargins": 1.0, "ebitdaMargins": 0.0, "operatingMargins": -4.31339, "financialCurrency": "USD", "symbol": "EVAX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "corporateActions": [], "postMarketTime": 1755288603, "regularMarketTime": 1755288000, "exchange": "NCM", "messageBoardId": "finmb_319014926", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketPrice": 2.88, "marketState": "CLOSED", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1612535400000, "regularMarketChangePercent": 0.6993084, "postMarketChangePercent": -1.0453, "postMarketPrice": 2.84, "postMarketChange": -0.03, "regularMarketChange": 0.02000022, "regularMarketDayRange": "2.811 - 2.94", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 115370, "fiftyTwoWeekLowChange": 1.6800001, "fiftyTwoWeekLowChangePercent": 1.4, "fiftyTwoWeekRange": "1.2 - 17.75", "fiftyTwoWeekHighChange": -14.87, "fiftyTwoWeekHighChangePercent": -0.8377465, "fiftyTwoWeekChangePercent": -83.033875, "earningsTimestamp": 1748345448, "earningsTimestampStart": 1755001800, "earningsTimestampEnd": 1755520200, "earningsCallTimestampStart": 1748349000, "earningsCallTimestampEnd": 1748349000, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -12.0, "epsForward": -1.26, "fiftyDayAverageChange": 0.22150016, "fiftyDayAverageChangePercent": 0.08331772, "twoHundredDayAverageChange": -0.83985496, "twoHundredDayAverageChangePercent": -0.22577626, "priceToBook": -2.4448218, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-02-05", "prevName": "Evaxion Biotech A/S", "nameChangeDate": "2025-08-15", "averageAnalystRating": "1.5 - Strong Buy", "shortName": "Evaxion A/S", "longName": "Evaxion A/S", "trailingPegRatio": null, "__fetch_time": "2025-08-16"}]